Development of a calcium phosphate co-precipitate/poly(lactide-co- glycolide) DNA delivery system: Release kinetics and cellular transfection studies

Biomaterials

Volumn 25, Issue 13, 2004, Pages 2637-2643

  Kofron, Michelle D ^a   Laurencin, Cato T ^a,b,c,d  

^a University of Virginia   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c University of Virginia   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Adsorption; Calcium phosphate co precipitates; Controlled delivery; DNA transfer; Poly(lactide co glycolide)

Indexed keywords

ADSORPTION; BIODEGRADATION; CALCIUM COMPOUNDS; CELL CULTURE; ENCAPSULATION; GENE TRANSFER; GENES;

CO-PRECIPITATION METHOD;

DNA;

CALCIUM PHOSPHATE; DNA; POLYGLACTIN;

ADSORPTION; ARTICLE; BACTERIOPHAGE LAMBDA; CELL CULTURE; CONTROLLED STUDY; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; KINETICS; NONVIRAL GENE DELIVERY SYSTEM; OSTEOBLAST; OSTEOSARCOMA CELL; POLYMERASE CHAIN REACTION; PRECIPITATION; PRIORITY JOURNAL;

EID: 0742324836     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2003.09.042     Document Type: Article

References (40)

1. Ramchandani M., Pankaskie M., Robinson D. The influence of manufacturing procedure on the degradation of poly(lactide-co-glycolide) 85:15 and 50:50 implants. J Control Release. 43:1997;161-173.
2. Athanasiou K.A., Agrawal C.M., Barber F.A., Burkhart S.S. Orthopaedic applications for PLA-PGA biodegradable polymers. Arthroscopy. 14:1998;726-737.
3. Jain R.A. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide)(PLGA) devices. Biomaterials. 21:2000;2475-2490.
4. Richardson T.P., Murphy W.L., Mooney D.J. Polymeric delivery of proteins and plasmid DNA for tissue engineering and gene therapy. Crit Rev Eukaryot Gene Expn. 11:2001;47-58.
5. Woo B.H., Fink B.F., Page R., Schrier J.A., Jo Y.W., Jiang G., DeLuca M., Vasconez H.C., DeLuca P.P. Enhancement of bone growth by sustained delivery of recombinant human bone morphogenetic protein-2 in a polymeric matrix. Pharm Res. 18:2001;1747-1753.
6. Duggirala S.S., Rodgers J.B., DeLuca P.P. The evaluation of lyophilized polymer matrices for administering recombinant human bone morphogenetic protein-2. Pharm Dev Technol. 1:1996;165-174.
7. Sheridan M.H., Shea L.D., Peters M.C., Mooney D.J. Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery. J Control Release. 64:2000;91-102.
8. Baldwin S.P., Saltzman W.M. Materials for protein delivery in tissue engineering. Adv Drug Deliv Rev. 33:1998;71-86.
9. Zhu G., Mallery S.R., Schwendeman S.P. Stabilization of proteins encapsulated in injectable poly(lactide-co-glycoldie). Nat Biotechnol. 18:2000;52-57.
10. Fu K., Klibanov A.M., Langer R. Protein stability in controlled-release systems. Nat Biotechnol. 18:2000;24-25.
11. Rosilio V., Benoit J.P., Deyme M., Thies C., Madelmont G. A physicochemical study of the morphology of progesterone-loaded microspheres fabricated from poly(D,L-lactide-co-gycolide). J Biomed Mater Res. 25:1991;667-682.
12. Bonadio J., Goldstein S.A., Levy R.J. Gene therapy for tissue repair and regeneration. Adv Drug Deliv Rev. 33:1998;53-69.
13. Scully S.P. Gene therapy clinical considerations. Clin Orthop. 379S:2000;S55-S58.
14. Le Doux J.M., Morgan J.R., Yarmush M.L. Gene therapy. CRC handbook of engineering in medicine and biology. 1995;1518-1533 CRC Press, Boca Raton, FL.
15. Wang F., Raab M., Washabaugh M.W., Buckland B.C. Gene therapy and metabolic engineering. Metab Eng. 2:2000;126-139.
16. Fibson W.J. Gene therapy. Clin Genet. 35:2000;757-772.
17. Walters R.W., Welsh M.J. Mechanism by which calcium phosphate coprecipitation enhances adenovirus-mediated gene transfer. Gene Therapy. 6:1999;1845-1850.
18. Scaduto A.A., Lieberman J.R. Gene therapy for osteoinduction. Orthop Clin North Am. 30:1999;625-633.
19. Shea L.D., Smiley E., Bonadio J., Mooney D.J. DNA delivery from polymer matrices for tissue engineering. Nat Biotechnol. 17:1999;551-554.
20. Goldstein S.A. In vivo nonviral delivery factors to enhance bone repair. Clin Orthop. 379S:2000;S113-S119.
21. Borden M.D., Attawia M.A., Khan Y., Laurencin C.T. Tissue engineered microsphere-based matrices for bone repair. design and evaluation Biomaterials. 23:2002;551-559.
22. Borden MD, Attawia, Laurencin CT. The sintered microsphere matrix for bone tissue engineering: in vitro osteoconductivity studies. J Biomed Mater Res 2002;61:421-29.
23. Schenborn E.T., Goiffon V. Calcium phosphate transfection of mammalian cultured cells. Methods Mol Biol. 130:2000;135-145.
24. Kouraklis G. Gene therapy for cancer. from the laboratory to the patient Dig Dis Sci. 45:2000;1045-1052.
25. Yin L.H., Fu S.Q., Nanakorn T., Garcia-Sanchez F., Chung I., Cote R., Pizzorno G., Hanania E., Heimfeld S., Crystal R., Deisseroth A. Results of retroviral and adenoviral approaches to cancer gene therapy. Stem Cells. 16(Suppl):1998;247-250.
26. Graham F.L., Van der Eb A.J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 52:1973;456-467.
27. Wilson S.P., Smith A. Addition of glycerol during DNA exposure enhances calcium phosphate transfection. Anal Biochem. 246:1997;148-150.
28. Chen C.A., Okayama H. Calcium phosphate-mediated gene transfer. a highly efficient transfection system for stably transforming cells with plasmid DNA BioTechniques. 6:1988;632-638.
29. Tolou H. Administration of oligonucleotides to cultured cells by calcium phosphate precipitation method. Anal Biochem. 215:1993;156-158.
30. Urabe M., Kume A., Tobita K., Ozawa K. DNA/calcium phosphate co-precipitates mixed with medium are stable and maintain high transfection efficiency. Anal Biochem. 278:2000;91-92.
31. Wilson S.P., Liu F., Wilson R.E., Housley P.R. Optimization of calcium phosphate transfection for bovine chromaffin cells. relationship to calcium phosphate precipitate formation Anal Biochem. 226:1995;212-220.
32. Seelos C. A critical parameter determining the aging of DNA-calcium-phosphate co-precipitates. Anal Biochem. 245:1997;109-111.
33. Nof M., Shea L.D. Drug-releasing scaffolds fabricated from drug-loaded microspheres. J Biomed Mater Res. 59:2002;349-356.
34. Madsen S., Mooney D.J. Delivering DNA with polymer mat5rices. application in tissue engineering and gene therapy PSTT. 3:2000;381-384.
35. Tinsley-Brown A.M., Fretwell R., Dowsett A.B., Davis S.L., Farrar G.H. Formulation of poly(D,L-lactic-co-glycolic acid) microparticles for rapid plasmid DNA delivery. J Control Release. 66:2000;229-241.
36. Luo D., Woodrow-Mumford K., Belcheva N., Saltzman W.M. Controlled DNA delivery systems. Pharm Res. 16:1999;1300-1308.
37. Ando S., Putnam D., Pack D.W., Langer R. PLGA microspheres containing plasmid DNA. preservation of supercoiled DNA via cryopreparation and carbohydrate stabilization J Pharm Sci. 88:1999;126-130.
38. Mahato R.I., Smith L.C., Rolland A. Pharmaceutical perspectives of nonviral gene therapy. Adv Genet. 41:1999;95-156.
39. Fang J, Zhu Y, Smiley E, Bonadio J, Rouleau. Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proc Nat Acad Sci USA 1996;93:5753-8.
40. Bonadio J. Tissue engineering via local gene delivery. update and future prospects for enhancing the technology Adv Drug Deliv Rev. 44:2000;185-194.